TABLE 1:

Summary of Response Evaluation Criteria in Solid Tumours V.1.0 (RECIST)23

Complete response (CR)Disappearance of all target lesions; pathological lymph nodes <10 mm short axis
Partial response (PR)≥30% decrease in sum diameters of target lesions, taking as reference the baseline sum
Stable disease (SD)<30% reduction (PR) or 20% increase (PD) in the sum diameters of target lesions, taking as reference the smallest sum of diameters while on study
Progressive disease (PD)≥20% increase in sum diameter of target lesions taking as reference the smallest sum of diameters while on study; the sum increase must be ≥5 mm, OR the appearance of one or more new lesions